Stratagene Secures Dismissal in Class Action

Represented the special committee of directors of Stratagene, a publicly traded manufacturer of life science research products, in class action litigation related to its acquisition by Agilent Technologies for more than $100 million. We secured a dismissal of the lawsuit with no payment to plaintiffs, and Stratagene was subsequently acquired by Agilent.